This invention provides compound having a structure of Formulas: Furthermore, methods and uses of such compounds for covalently bonding to a sugar acceptor, to form modified protein therapeutics having reduced enzymatic hydrolysis, improved biological stability or an improved pharmacokinetic property.
本发明提供具有式结构的化合物:此外,还提供了此类化合物与糖受体共价键合的方法和用途,以形成具有减少酶
水解、提高
生物稳定性或改善药代动力学特性的改性蛋白质治疗剂。